---
title: bioaccess Reviews
meta_title: 'bioaccess Reviews 2026: Details, Pricing, & Features | G2'
meta_description: Filter reviews by the users' company size, role or industry to find
  out how bioaccess works for a business like yours.
date_modified: '2026-04-05'
parent_category:
  name: Health Services
  url: https://www.g2.com/categories/health-services
---

# bioaccess Reviews
**Vendor:** bioaccess  
**Category:** [Other Healthcare Services Providers](https://www.g2.com/categories/other-healthcare-services)
## About bioaccess
bioaccess® is the world's first and only CRO purpose-built for first-in-human clinical trials — serving MedTech, biopharma, and radiopharma startups across Latin America and beyond. While traditional CROs offer FIH as one of dozens of services buried in an enterprise menu, bioaccess® was founded for this singular mission: getting breakthrough healthcare innovations into human trials faster, at lower cost, and with investor-ready data from day one. Healthcare startups developing breakthrough MedTech devices, Biopharma therapeutics, and Radiopharma treatments face a critical bottleneck: generating the clinical data investors and acquirers demand — before the money runs out. Traditional CROs are built for big pharma running Phase III mega-trials. They move slowly, charge premium rates, and treat early-stage startups as an afterthought. The result? Promising innovations die in the valley of death — not because the science failed, but because the clinical pathway took too long and cost too much. bioaccess® was founded in 2010 to solve this exact problem. We are the world's first and only contract research organization built from day one exclusively around first-in-human clinical trials for healthcare startups. We created a new category in clinical research — one that matches the speed, urgency, and capital constraints of founders raising rounds, engaging strategic acquirers, and racing toward exits. Who We Serve: Seed-stage to growth-stage startups across MedTech, Biopharma, and Radiopharma — companies that need human proof-of-concept data to unlock their next milestone. What Makes Us Different: Through our proprietary Innovation Runway — the world's first clinical development pathway built exclusively for FIH trials — we deliver ethics approval in 4–8 weeks, compress timelines by 40%, and reduce costs by 30% compared to US/EU-only approaches. Every study is 100% ICH-GCP aligned, producing FDA/EMA-ready data with no rework required. We operate across 10 countries in Latin America, including Colombia, Mexico, Brazil, Chile, Argentina, Panama, Ecuador, El Salvador, Dominican Republic, and Paraguay — giving startups access to treatment-naive patient cohorts enrolled 50% faster than US sites. Since 2010, bioaccess® has accelerated 58+ companies from seed-stage startups to Fortune 500 MedTech — proving that the fastest path from prototype to clinical milestones runs through Latin America. Headquartered in Miami, FL. Learn more at bioaccessla.com.






- [View bioaccess pricing details and edition comparison](https://www.g2.com/products/bioaccess/reviews?section=pricing&secure%5Bexpires_at%5D=2026-07-13+20%3A51%3A46+-0500&secure%5Bsession_id%5D=971d6402-f607-470c-88dd-c416c7e65496&secure%5Btoken%5D=5b4b68e0f5cf66d553387bf79d5d05e7f852c0dad2f2f5ebce080cb61795a891&format=llm_user)

## bioaccess Features
**Planning**
- Needs Assessment
- Resource Allocation
- Stayed within Budget
- Statement of Work
- Best Practices

**Delivery**
- Technical Expertise
- Met Deadlines
- Meeting Management
- Project Updates
- Scope Management
- Roll-out

**Team Quality**
- Change Management Skills
- Executive Presence
- Vertical Expertise
- Technology Partnerships

## Top bioaccess Alternatives
  - [Optum Advisory Services](https://www.g2.com/products/optum-advisory-services/reviews) - 3.3/5.0 (16 reviews)
  - [CareMe Health](https://www.g2.com/products/careme-health/reviews) - 4.5/5.0 (13 reviews)
  - [healthgrades Quality Solutions](https://www.g2.com/products/healthgrades-quality-solutions/reviews) - 3.8/5.0 (11 reviews)